News archive search
Search the Newsreel
Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.
- Showing
- 181–216
- Matches
- 2611
- Sources here
- 25
- Companies here
- 29
Active search
2611 matching headlines
Search results
Matching headlines
External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.
ICE Stock Gains as Ackman Backs Brent-Futures Fortress
This article first appeared on GuruFocus. Intercontinental Exchange (NYSE:ICE), the financial-market powerhouse behind exchanges, clearing networks and data platforms, gained approximately 0.9% Thursday morning after Pershing Square revealed a new position. And this one is not hard to understand. Pershing sees ICE trading at …
Sharemaestro market context Price below Trend Line 52 weeks -23.2% · Next-week setup negative 36.7%DuPont Direct Lithium Extraction Team Named 2026 Sustainability Squad by Business Intelligence Group
DuPont's Direct Lithium Extraction (DLE) team has been named a "Sustainability Squad" by the Business Intelligence Group for their work in developing and commercializing DLE technologies. This recognition highlights their end-to-end DLE portfolio, which includes over 20 products designed to optimize lithium recovery from …
Sharemaestro market context Trend signal active 52 weeks +102.5% · Next-week setup negative 19.5%Analysts Offer Insights on Healthcare Companies: Immunic (IMUX), Legend Biotech (LEGN) and Sagimet Biosciences, Inc. Class A (SGMT)
Three analysts have issued bullish sentiments on healthcare companies Immunic (IMUX), Legend Biotech (LEGN), and Sagimet Biosciences, Inc. Class A (SGMT). William Blair reiterated a Buy rating on Immunic, H.C. Wainwright reiterated a Buy on Legend Biotech with a $65.00 price target, and Wedbush …
Toronto Dominion Bank Price Target Raised to C$190.00/Share From C$162.00 by National Bank
National Bank has increased its price target for Toronto Dominion Bank (TD) to C$190.00 per share, up from the previous C$162.00. This adjustment reflects a more optimistic outlook on the bank's future performance.
Newmont Corp. stock underperforms Thursday when compared to competitors
Newmont Corp. stock (NEM) fell by 3.10% to $114.19 on Thursday, underperforming the broader market which saw the S&P 500 Index rise by 0.65% and the Dow Jones Industrial Average increase by 0.13%. The company's shares closed 15.34% below its 52-week high of $134.88, …
Earnings Estimates Rising for Onto Innovation (ONTO): Will It Gain?
Onto Innovation (ONTO) could be a solid addition to your portfolio given a notable revision in the company's earnings estimates. While the stock has been gaining lately, the trend might continue since its earnings outlook is still improving. Analysts' growing optimism on the earnings …
Sharemaestro market context Trend signal active 52 weeks +131.2% · Next-week setup negative 12.4%Kontoor Brands Could Evolve as 'Growth Stock' After Lee Sale, UBS Says
Kontoor Brands (KTB) has the potential to become a "growth stock" after selling its Lee brand, given PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premium news articles. Upgrade …
Kontoor Brands Reports 2026 Second; Quarter Results and Raises Full Year; Outlook; Expects to Enter Into a $400; Million Accelerated Share Repurchase Agreement
Kontoor Brands (NYSE: KTB) reported strong second-quarter 2026 results, with revenue from continuing operations increasing 19% to $584 million, significantly boosted by Helly Hansen. The company also raised its full-year 2026 adjusted EPS outlook to $5.25-$5.35 and anticipates entering into a $400 million Accelerated …
Earnings call transcript: Biofrontera tops Q2 2026 estimates, shares jump 9.6%
Biofrontera reported strong Q2 2026 results with a 33% increase in net product revenue to $12 million and gross margin of 80%, achieving near breakeven adjusted EBITDA. The company highlighted ongoing commercial momentum, including an 18.6% increase in first-half order count, and provided updates …
UBS raises Kontoor Brands stock price target to $136 on growth outlook
UBS has increased its price target for Kontoor Brands (NYSE:KTB) to $136 from $131, maintaining a Buy rating due to the company's strong brands and long-term growth opportunities. The firm anticipates the company will evolve into a growth stock, driven by sales improvement, margin …
Newmont & Barrick Settle Nevada Gold Mines Dispute Clearing Barrick IPO Path
Newmont Corp. and Barrick Mining Corp. have resolved disputes concerning their Nevada Gold Mines joint venture, with Barrick's Fourmile project and Newmont's Fiberline and Mike projects being contributed to the partnership. Newmont will provide Barrick with US$1.95 billion for these assets, which clears the …
Form 8K Biofrontera Inc For: 13 August By Investing.com
This article reports that Biofrontera Inc. filed a Form 8K on August 13. The filing is a standard disclosure document used by companies to announce significant events that investors should know about. No specific details about the content of the 8K filing are provided …
Price to earnings forward of Biofrontera Inc. – BOATS:BFRIW
The article discusses the "Price to earnings forward" metric for Biofrontera Inc. (BFRIW), listed on the Blue Ocean Alternative Trade System (BOATS). It appears to be a stub or a data point from a financial platform, indicating market closed status and no trades, with …
Biofrontera Inc. (BFRI) Reports Q2 Loss, Beats Revenue Estimates
Biofrontera Inc. (BFRI) reported a Q2 loss of $0.05 per share, exceeding the Zacks Consensus Estimate of a $0.17 loss, and posted revenues of $12 million, surpassing estimates by 33.37%. Despite a mixed trend in estimate revisions leading up to the report, the company …
BioNTech Just Named a New CEO. Here's What Guido Oelkers' Appointment Means for the Stock.
BioNTech has appointed Guido Oelkers, former CEO of Sobi, as its new chief executive, effective by February 1, 2027. This leadership change is a planned transition to steer BioNTech toward a diversified oncology pipeline, moving beyond its primary focus on COVID-19 vaccines. Oelkers' experience …
Sharemaestro market context Price below Trend Line 52 weeks -24.3% · Next-week setup negative 30.5%Folketrygdfondet reports 4.5% Frontline plc (FRO) holding in amended 13G
Folketrygdfondet has filed an amended 13G stating a 4.5% beneficial ownership in Frontline plc (FRO), totaling 10,082,471 common shares. This ownership includes sole voting and sole dispositive power over all reported shares, based on 222,622,889 shares outstanding as of March 31, 2026. The filing …
Onterris secures $9M in new awards from energy client By Investing.com
Onterris (NYSE:ONT) has secured over $9 million in new project awards during the first half of 2026 from an undisclosed integrated energy company. This expands on a multi-million-dollar, five-year contract from 2025 and reinforces a relationship spanning over 20 years, during which Onterris provides …
BIOFRONTERA ($BFRI) Releases Q2 2026 Earnings
Biofrontera Inc (BFRI) reported strong Q2 2026 results, driven by significant Ameluz growth and successful commercial expansion, leading to increased revenue and improved gross margins. Despite heightened operating expenses and competition, the company maintains a solid cash position and projects 30-35% revenue growth for …